Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Injectable Platelet-Rich Fibrin Added to MINST for Grade II Furcation Defects

Official title: Evaluation of Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Grade II Furcation Defects: A Randomized Clinical Trial

Run by October 6 University · NCT07787949 · Data updated 2026-11-12

Aiming to see if adding injectable platelet-rich fibrin to a minimally invasive non-surgical cleaning helps treat certain tooth defects better than MINST alone.

More Minimally Invasive Surgical Procedures trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorOctober 6 University
Academic / other
Locations1 site (Giza, Giza Governorate)
StatusRecruiting
StartedMarch 11, 2026
Main results expectedMarch 11, 2027
Study endsMarch 11, 2027
Registry record updatedAugust 26, 2026
Trial IDNCT07787949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with stage III, grade B periodontitis and a class II furcation defect, good oral hygiene, and commitment to follow-up.

Probably not a fit

Patients with systemic conditions affecting regeneration, smokers, recent periodontal surgery, or those who cannot follow up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares MINST alone to MINST plus injectable platelet-rich fibrin (i-PRF) for managing class II furcation defects in adults with Stage III, Grade B periodontitis. It uses magnification during debridement to preserve tissue and enhance root decontamination, with the experimental arm receiving i-PRF to potentially boost regenerative outcomes. Outcomes will be assessed clinically and radiographically to determine whether the combination improves tissue stability and defect resolution. The study is conducted at October 6 University, with participants meeting specific inclusion criteria and agreeing to ongoing maintenance follow-up. The design focuses on real-world applicability of a minimally invasive approach augmented by a biologic agent.

Why it matters

Potential benefit: If successful, patients could experience greater defect resolution and improved periodontal stability with a less invasive treatment.

How similar studies have gone: Other studies have shown promise with MINST and regenerative adjuncts, but results vary and this specific combination is being tested in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of both genders \>18 years old, medically free of systemic diseases affecting periodontal regeneration.
* Diagnosis of stage III, grade B periodontitis (according to the AAP/EFP classification 2018) with the presence of class II furcation defect in either the maxillary (buccal) or mandibular arch (buccal or lingual) as determined by clinical evaluation and confirmed by radiographic evaluation.
* Gingival margin and interdental bone positioned coronally to the furcation entrance.
* Commitment to maintenance visits and follow-up.
* Absence of primary endodontic lesions.

Exclusion Criteria:

* Patients suffering from any systemic diseases that may affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc;
* Patients that received periodontal surgical treatments in the past 12 months.
* Smoking (current or in past 5 years)
* Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months prior to periodontal therapy.
* Pregnant and lactating females.
* Teeth with hopeless prognosis
* Third molars

Where it's running

  • October 6 University (Faculty of Dentistry)
    Giza, Giza Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.